1
|
Berrino F, Villarini A, Gargano G, Krogh V, Grioni S, Bellegotti M, Venturelli E, Raimondi M, Traina A, Zarcone M, Amodio R, Mano MP, Johansson H, Panico S, Santucci de Magistris M, Barbero M, Gavazza C, Mercandino A, Consolaro E, Galasso R, Del Riccio L, Bassi MC, Simeoni M, Premoli P, Pasanisi P, Bonanni B, Bruno E. The Effect of Diet on Breast Cancer Recurrence: The DIANA-5 Randomized Trial. Clin Cancer Res 2024; 30:965-974. [PMID: 37847493 PMCID: PMC10905522 DOI: 10.1158/1078-0432.ccr-23-1615] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2023] [Revised: 08/02/2023] [Accepted: 10/13/2023] [Indexed: 10/18/2023]
Abstract
PURPOSE The DIANA-5 randomized controlled trial assessed the effectiveness of a diet based on Mediterranean and macrobiotic traditions (macro-Mediterranean diet) in reducing breast cancer recurrence. PATIENTS AND METHODS The DIANA-5 study involved 1,542 patients with breast cancer at high risk of recurrence because of estrogen receptor-negative cancer, or metabolic syndrome, or high plasma levels of insulin or testosterone. Women were randomly assigned to an active dietary intervention (IG) or a control group (CG). Both groups received the 2007 American Institute for Cancer Research/World Cancer Research Fund recommendations for cancer prevention. The intervention consisted of meetings with kitchen classes, community meals, and dietary recommendations. Recommended foods included whole grain cereals, legumes, soy products, vegetables, fruit, nuts, olive oil, and fish. Foods to be avoided were refined products, potatoes, sugar and desserts, red and processed meat, dairy products, and alcoholic drinks. A compliance Dietary Index was defined by the difference between recommended and discouraged foods. RESULTS Over the 5 years of follow-up, 95 patients of the IG and 98 of the CG developed breast cancer recurrence [HR = 0.99; 95% confidence interval (CI): 0.69-1.40]. The analysis by compliance to the dietary recommendations (IG and CG together) showed that the women in the upper tertile of Dietary Index change had an HR of recurrence of 0.59 (95% CI: 0.36-0.92) compared with women in the lower tertile. CONCLUSIONS The DIANA-5 dietary intervention trial failed to show a reduction in breast cancer recurrence, although self-reported diet at year 1 in IG and CG combined showed a protective association with the higher Dietary Index change. See related commentary by McTiernan, p. 931.
Collapse
Affiliation(s)
- Franco Berrino
- Department of Epidemiology and Data Science, S.C. Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
- La Grande Via Foundation, Milan, Italy
| | - Anna Villarini
- Department of Medicine and Surgery, Section of Hygiene and Public Health, University of Perugia, Perugia, Italy
| | - Giuliana Gargano
- Department of Epidemiology and Data Science, S.C. Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Vittorio Krogh
- Department of Epidemiology and Data Science, S.C. Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Sara Grioni
- Department of Epidemiology and Data Science, S.C. Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Manuela Bellegotti
- Department of Epidemiology and Data Science, S.C. Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Elisabetta Venturelli
- Department of Experimental Oncology, S.S.D. Nutrition Research and Metabolomics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Milena Raimondi
- Department of Epidemiology and Data Science, S.C. Epidemiology and Prevention, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Adele Traina
- Palermo and Province Cancer Registry, Clinical Epidemiology Unit with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”, University of Palermo, Palermo, Italy
| | - Maurizio Zarcone
- Palermo and Province Cancer Registry, Clinical Epidemiology Unit with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”, University of Palermo, Palermo, Italy
| | - Rosalba Amodio
- Palermo and Province Cancer Registry, Clinical Epidemiology Unit with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”, University of Palermo, Palermo, Italy
| | - Maria Piera Mano
- Dipartimento Scienze Chirurgiche, Study University, Turin, Italy
- S.C. Epidemiologia dei Tumori, AOU Città della Salute e della Scienza, CPO Piemonte, Turin, Italy
| | - Harriet Johansson
- Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | | | | | | | | | | | | | - Rocco Galasso
- Unit of Regional Cancer Registry, Clinical Epidemiology and Biostatistics, IRCCS-CROB, Rionero in Vulture, Italy
| | - Luciana Del Riccio
- Unit of Regional Cancer Registry, Clinical Epidemiology and Biostatistics, IRCCS-CROB, Rionero in Vulture, Italy
| | | | | | | | - Patrizia Pasanisi
- Department of Experimental Oncology, S.S.D. Nutrition Research and Metabolomics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| | - Bernardo Bonanni
- Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy
| | - Eleonora Bruno
- Department of Experimental Oncology, S.S.D. Nutrition Research and Metabolomics, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy
| |
Collapse
|
2
|
Segala FV, Ictho J, L'Episcopia M, Onapa E, De Vita E, Novara R, Olung N, Totaro V, Olal L, Patti G, Bingom C, Farina U, Papagni R, Agaro C, Bavaro DF, Amone J, Dall'Oglio G, Ngole B, Marotta C, Okori S, Zarcone M, Ogwang J, Severini C, Lochoro P, Putoto G, Saracino A, Di Gennaro F. Impact of the COVID-19 pandemic on malaria in pregnancy indicators in Northern Uganda: a joinpoint regression analysis. Pathog Glob Health 2023:1-9. [PMID: 37872763 DOI: 10.1080/20477724.2023.2273023] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2023] Open
Abstract
BACKGROUND Pregnancy is both a risk factor for P. falciparum infection and development of severe malaria. In low- and middle-income countries, the COVID-19 pandemic severely impacted health systems, including utilization of maternal services. This study aimed to assess trends in delivering malaria in pregnancy-related health-care services before and during COVID-19 in Northern Uganda. METHODS An interrupted time-series study comparing pre-COVID-19 (January 2018 to April 2020) and COVID-19 (May to December 2021) periods, based on the date the first COVID case was detected. The study involved 30 health facilities in Northern Uganda with 22,650 estimated pregnancies per year, 14% of which took place in hospital. Monthly data were sourced from District routinely collected indicators. Trends were analyzed by joinpoint regression models. RESULTS From the onset of the COVID pandemic in Uganda (May 2020), we found a significant reduction in the number of women accessing a fourth antenatal care visit (from APC + 183.5 to + 4.98; p < 0.001) and taking at least three doses of intermittent preventive treatment in pregnancy (IPTp, from APC + 84.28 to -63.12; p < 0.001). However, we found no significant change in the trend of the total number of pregnant women managed as outpatients or hospitalized for malaria, as well as in the number of women attending their first antenatal visit and in the number of institutional deliveries. CONCLUSIONS In our study, the COVID-19 pandemic significantly reduced access to ANC visits and IPTp uptake. However, the healthcare system maintained its capacity for managing malaria cases, first antenatal visits, and institutional deliveries.Trial registration: This study has been registered on the ClinicalTrials.gov public website on 26 April 2022. ClinicalTrials.gov Identifier: NCT05348746.
Collapse
Affiliation(s)
- Francesco Vladimiro Segala
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - Jerry Ictho
- Health Service Management, Doctors with Africa CAUMM, Kampala, Uganda
| | | | - Emmanuel Onapa
- Operational Research Unit, St. John's XXIII Hospital Aber, Jaber, Uganda
| | - Elda De Vita
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - Roberta Novara
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - Nelson Olung
- Operational Research Unit, St. John's XXIII Hospital Aber, Jaber, Uganda
| | - Valentina Totaro
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - Lameck Olal
- Operational Research Unit, African Network for Change, Kampala, Uganda
| | - Giulia Patti
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | | | - Umberto Farina
- Hygiene Unit, Policlinico Riuniti Foggia Hospital, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy
| | - Roberta Papagni
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - Caroline Agaro
- Health Office, Oyam District Local Government, Loro, Uganda
| | - Davide Fiore Bavaro
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - James Amone
- Operational Research Unit, St. John's XXIII Hospital Aber, Jaber, Uganda
| | | | - Benedict Ngole
- Operational Research Unit, African Network for Change, Kampala, Uganda
| | - Claudia Marotta
- Operational Research Unit, Doctors with Africa CUAMM, Padua, Italy
| | - Samuel Okori
- Operational Research Unit, St. John's XXIII Hospital Aber, Jaber, Uganda
| | - Maurizio Zarcone
- Unità Operativa Complessa di Epidemiologia Clinica con Registro Tumori, Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone", Palermo, Italy
| | - Joseph Ogwang
- Operational Research Unit, St. John's XXIII Hospital Aber, Jaber, Uganda
| | - Carlo Severini
- Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy
| | - Peter Lochoro
- Health Service Management, Doctors with Africa CAUMM, Kampala, Uganda
| | - Giovanni Putoto
- Health Service Management, Doctors with Africa CAUMM, Kampala, Uganda
| | - Annalisa Saracino
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| | - Francesco Di Gennaro
- Department of Precision and Regenerative Medicine and Ionian Area, Clinic of Infectious Diseases, University of Bari "Aldo Moro", Bari, Italy
| |
Collapse
|
3
|
Restivo V, Bruno A, Minutolo G, Pieri A, Riggio L, Zarcone M, Candiloro S, Caldarella R, Immordino P, Amodio E, Casuccio A. Changes in Students' Perceptions Regarding Adolescent Vaccinations through a Before-After Study Conducted during the COVID-19 Pandemic: GIRASOLE Project Study. Vaccines (Basel) 2023; 11:1524. [PMID: 37896928 PMCID: PMC10610628 DOI: 10.3390/vaccines11101524] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2023] [Revised: 09/22/2023] [Accepted: 09/22/2023] [Indexed: 10/29/2023] Open
Abstract
The COVID-19 pandemic caused a reduction in vaccination coverage for all age groups, especially in non-infant age. The main objective of the present study is to evaluate the effectiveness of an online intervention conducted among adolescents during the COVID-19 pandemic in increasing knowledge and positive attitudes toward vaccinations. The study, which took place online from March to May 2021, involved 267 students from six lower secondary schools in Palermo city (Italy); they filled out the questionnaire before and after the intervention. The questionnaire was based on the protection motivation theory (PMT), which estimates the improvement in vaccination-related knowledge and attitudes. The pre- and post-intervention comparison showed a significant increase in the perception of the disease severity: strongly agree pre-intervention n = 150 (58.6%) and post-intervention n = 173 (67.6%, p < 0.001), rated on a five-point Likert scale. In a multivariate analysis, the factor associated with the improvement in the score after the intervention was the school dropout index (low vs. very high dropout index OR 4.5; p < 0.03). The educational intervention was more effective in schools with lower early school leaving rates, an indirect index of socio-economic status. The topic of vaccination has caught the adolescents' attention, it is, therefore, important that interventions tackling teenagers are tailored to reduce their emotional tension about the perception of adverse effects and improve vaccination coverage.
Collapse
Affiliation(s)
- Vincenzo Restivo
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Alessandra Bruno
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Giuseppa Minutolo
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Alessia Pieri
- Clinical Epidemiology and Cancer Registry Unit, University Hospital “P. Giaccone”, Via del Vespro 133, 90127 Palermo, Italy; (A.P.); (M.Z.); (R.C.)
| | - Luca Riggio
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Maurizio Zarcone
- Clinical Epidemiology and Cancer Registry Unit, University Hospital “P. Giaccone”, Via del Vespro 133, 90127 Palermo, Italy; (A.P.); (M.Z.); (R.C.)
| | - Stefania Candiloro
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Rosalia Caldarella
- Clinical Epidemiology and Cancer Registry Unit, University Hospital “P. Giaccone”, Via del Vespro 133, 90127 Palermo, Italy; (A.P.); (M.Z.); (R.C.)
| | - Palmira Immordino
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Emanuele Amodio
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| | - Alessandra Casuccio
- Department of Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE) “G. D’Alessandro”, University of Palermo, Via del Vespro 133, 90127 Palermo, Italy; (A.B.); (G.M.); (L.R.); (S.C.); (P.I.); (E.A.); (A.C.)
| |
Collapse
|
4
|
Brusca I, Barrale M, Zarcone M, Fruscione S, Onida R, De Bella DD, Alba D, Belluzzo M, Uasuf CG, Cammilleri G, Costa A, Ferrantelli V, Savatteri A, Cannizzaro E, Calamusa G, Lacca G, Maida CM, Pipitone S, D'Atria A, Palomba M, Costantino C, Mattiucci S, Mazzucco W. Basophil Activation Test in the Diagnosis of Anisakis Allergy: An Observational Study from an Area of High Seafood Consumption in Italy. Pathogens 2023; 12:777. [PMID: 37375467 DOI: 10.3390/pathogens12060777] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2023] [Revised: 05/23/2023] [Accepted: 05/25/2023] [Indexed: 06/29/2023] Open
Abstract
The rising popularity of undercooked or raw seafood containing larvae of the Anisakis parasite has led to issues of public health concern due to allergic manifestations. We conducted an observational study on the use of an innovative Anisakis allergy diagnostic algorithm in a convenience sample of 53 allergic outpatients recruited in Western Sicily, between April 2021 and March 2022. We included individuals with an anamnesis suggestive of IgE sensitization to Anisakis reporting clinical manifestation in the last month due to allergic reactions after eating fresh fish, or in subjects at high exposure risk with sea products while abstaining from fish ingestion, excluding those with documented fish sensitization. Outpatients were tested via Skin Prick Test, IgE-specific dosage and Basophil Activation Test (BAT). Twenty-six outpatients were diagnosed with Anisakis, while 27 with Chronic Urticaria (CU). We found a seven-fold excess risk for Anisakis (p4) positivity in the Anisakis allergic outpatients, as compared to the CU ones. BAT showed the best diagnostic accuracy (92.45%) and specificity (100%), while specific IgE to Ascaris (p1) documented the best sensitivity (92.31%) but a very low specificity (37.04%). In conclusion, our findings may represent a potentially useful contribution to the future development of updated clinical guidelines.
Collapse
Affiliation(s)
- Ignazio Brusca
- U.O.C of Clinical Pathology Buccheri La Ferla Hospital FBF, 90123 Palermo, Italy
| | - Maria Barrale
- U.O.C of Clinical Pathology Buccheri La Ferla Hospital FBF, 90123 Palermo, Italy
| | - Maurizio Zarcone
- U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, 90127 Palermo, Italy
| | - Santo Fruscione
- PROMISE Department, University of Palermo, 90127 Palermo, Italy
| | - Rosa Onida
- U.O.C of Clinical Pathology Buccheri La Ferla Hospital FBF, 90123 Palermo, Italy
| | | | - Davide Alba
- PROMISE Department, University of Palermo, 90127 Palermo, Italy
| | - Miriam Belluzzo
- PROMISE Department, University of Palermo, 90127 Palermo, Italy
| | - Carina Gabriela Uasuf
- Allergy Disease Center, Institute of Translational Pharmacology (IFT), National Research Council (CNR), 90146 Palermo, Italy
| | | | - Antonella Costa
- Experimental Zooprophylactic Institute of Sicily, 90129 Palermo, Italy
| | | | | | | | | | - Guido Lacca
- PROMISE Department, University of Palermo, 90127 Palermo, Italy
| | | | - Salvatore Pipitone
- U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, 90127 Palermo, Italy
| | - Alida D'Atria
- U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, 90127 Palermo, Italy
| | - Marialetizia Palomba
- Department of Ecological and Biological Sciences, Tuscia University, 01100 Viterbo, Italy
| | | | - Simonetta Mattiucci
- Department of Public Health and Infectious Diseases, Section of Parasitology, Sapienza-University of Rome, University Hospital "Policlinico Umberto I", 00185 Rome, Italy
| | - Walter Mazzucco
- U.O.C. of Clinical Epidemiology with Cancer Registry, Azienda Ospedaliera Universitaria Policlinico di Palermo, 90127 Palermo, Italy
- PROMISE Department, University of Palermo, 90127 Palermo, Italy
- College of Medicine, University of Cincinnati, Cincinnati, OH 45267, USA
| |
Collapse
|
5
|
Bruno E, Krogh V, Gargano G, Grioni S, Bellegotti M, Venturelli E, Panico S, Santucci de Magistris M, Bonanni B, Zagallo E, Mercandino A, Bassi MC, Amodio R, Zarcone M, Galasso R, Barbero M, Simeoni M, Mano MP, Berrino F, Villarini A, Pasanisi P. Adherence to Dietary Recommendations after One Year of Intervention in Breast Cancer Women: The DIANA-5 Trial. Nutrients 2021; 13:nu13092990. [PMID: 34578868 PMCID: PMC8468802 DOI: 10.3390/nu13092990] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2021] [Revised: 08/23/2021] [Accepted: 08/25/2021] [Indexed: 11/16/2022] Open
Abstract
The Diet and Androgen-5 (DIANA-5) trial aimed at testing whether a dietary change based on the Mediterranean diet and on macrobiotic principles can reduce the incidence of breast cancer (BC)-related events. We analyzed the adherence to the DIANA-5 dietary recommendations by randomization group after 1 year of intervention. We evaluated the association between dietary adherence and changes in body weight and metabolic syndrome (MS) parameters. BC women aged 35-70 years were eligible. After the baseline examinations, women were randomized into an intervention group (IG) or a control group (CG). A total of 1344 BC women (689 IG and 655 CG) concluded the first year of dietary intervention. IG showed greater anthropometric and metabolic improvements compared to CG. These changes were significantly associated with increased adherence to the dietary recommendations. Women who increased recommended foods consumption or reduced discouraged foods consumption showed an Odds Ratio (OR) of 1.37 (0.70-2.67) and 2.02 (1.03-3.98) to improve three or more MS parameters. Moreover, women in the higher category of dietary change showed a four times higher OR of reducing body weight compared to the lower category (p < 0.001). The DIANA-5 dietary intervention is effective in reducing body weight and MS parameters.
Collapse
Affiliation(s)
- Eleonora Bruno
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | - Vittorio Krogh
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | - Giuliana Gargano
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
- Correspondence: ; Tel.: +39-022-390-3514; Fax: +39-022-390-3516
| | - Sara Grioni
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | - Manuela Bellegotti
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | - Elisabetta Venturelli
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | | | | | - Bernardo Bonanni
- Division of Cancer Prevention and Genetics, European Institute of Oncology IRCCS, 20141 Milano, Italy; (B.B.); (E.Z.)
| | - Emanuela Zagallo
- Division of Cancer Prevention and Genetics, European Institute of Oncology IRCCS, 20141 Milano, Italy; (B.B.); (E.Z.)
| | | | | | - Rosalba Amodio
- Clinical Epidemiology and Cancer Registry Unit, Palermo Province Cancer Registry, Palermo University Hospital P. Giaccone, 90127 Palermo, Italy; (R.A.); (M.Z.)
| | - Maurizio Zarcone
- Clinical Epidemiology and Cancer Registry Unit, Palermo Province Cancer Registry, Palermo University Hospital P. Giaccone, 90127 Palermo, Italy; (R.A.); (M.Z.)
| | - Rocco Galasso
- Unit of Regional Cancer Registry, Clinical Epidemiology and Biostatistics, IRCCS-CROB, Basilicata, 85028 Rionero in Vulture, Italy;
| | - Maggiorino Barbero
- Obstetrics and Gynecology Unit, Cardinal Massaia Hospital, 14100 Asti, Italy;
| | | | - Maria Piera Mano
- Dipartimento Scienze Chirurgiche, Study University, 10124 Turin, Italy;
- S.C. Epidemiologia dei Tumori, AOU Città della Salute e della Scienza, CPO Piemonte, 10126 Turin, Italy
| | - Franco Berrino
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | - Anna Villarini
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| | - Patrizia Pasanisi
- Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, 20133 Milano, Italy; (E.B.); (V.K.); (S.G.); (M.B.); (E.V.); (F.B.); (A.V.); (P.P.)
| |
Collapse
|
6
|
Amodio E, Zarcone M, Casuccio A, Vitale F. Trends in epidemiology: the role of denominator fluctuation in population based estimates. AIMS Public Health 2021; 8:500-506. [PMID: 34395700 PMCID: PMC8334628 DOI: 10.3934/publichealth.2021040] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Accepted: 07/05/2021] [Indexed: 11/28/2022] Open
Abstract
Background Population estimates are of paramount importance for calculating occurrence and association measures although they can be affected by problems of accuracy and completeness. This study has performed a simulation of the impact of Italian population size variability on incidence rates. Methods Data have been obtained by the Italian National Institute of Statistics. For each year expected cases were calculated at increasing fixed rates (up to 1,000/100,000) and were considered constant in the “following year”, calculating statistical differences (P < 0.05). Results In Italy and in other regions, statistically significant higher RRs were found in 2012 vs. 2011 whereas statistically significant lower RRs were found in 2013 vs. 2012 and in 2014 vs. 2013. Contribution The simulation confirms that significant differences due to population fluctuation could be found between consecutive years when investigating diseases with medium-high rates. Researchers should be encouraged to implement actions for reducing the risk of biased population denominators.
Collapse
Affiliation(s)
- Emanuele Amodio
- University of Palermo, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties "G. D'Alessandro". Via Del Vespro 133, Palermo, Italy
| | - Maurizio Zarcone
- University of Palermo, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties "G. D'Alessandro". Via Del Vespro 133, Palermo, Italy
| | - Alessandra Casuccio
- University of Palermo, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties "G. D'Alessandro". Via Del Vespro 133, Palermo, Italy
| | - Francesco Vitale
- University of Palermo, Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties "G. D'Alessandro". Via Del Vespro 133, Palermo, Italy
| |
Collapse
|
7
|
Mazzucco W, Vitale F, Mazzola S, Amodio R, Zarcone M, Alba D, Marotta C, Cusimano R, Allemani C. Does access to care play a role in liver cancer survival? The ten-year (2006-2015) experience from a population-based cancer registry in Southern Italy. BMC Cancer 2021; 21:307. [PMID: 33761907 PMCID: PMC7988914 DOI: 10.1186/s12885-021-07935-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2020] [Accepted: 02/18/2021] [Indexed: 11/23/2022] Open
Abstract
Background Hepatocellular carcinoma (HCC) is the most frequent primary invasive cancer of the liver. During the last decade, the epidemiology of HCC has been continuously changing in developed countries, due to more effective primary prevention and to successful treatment of virus-related liver diseases. The study aims to examine survival by level of access to care in patients with HCC, for all patients combined and by age. Methods We included 2018 adult patients (15–99 years) diagnosed with a primary liver tumour, registered in the Palermo Province Cancer Registry during 2006–2015, and followed-up to 30 October 2019. We obtained a proxy measure of access to care by linking each record to the Hospital Discharge Records and the Ambulatory Discharge Records. We estimated net survival up to 5 years after diagnosis by access to care (“easy access to care” versus “poor access to care”), using the Pohar-Perme estimator. Estimates were age-standardised using International Cancer Survival Standard (ICSS) weights. We also examined survival by access to care and age (15–64, 65–74 and ≥ 75 years). Results Among the 2018 patients, 62.4% were morphologically verified and 37.6% clinically diagnosed. Morphologically verified tumours were more frequent in patients aged 65–74 years (41.6%), while tumours diagnosed clinically were more frequent in patients aged 75 years or over (50.2%). During 2006–2015, age-standardised net survival was higher among HCC patients with “easy access to care” than in those with “poor access to care” (68% vs. 48% at 1 year, 29% vs. 11% at 5 years; p < 0.0001). Net survival up to 5 years was higher for patients with “easy access to care” in each age group (p < 0.0001). Moreover, survival increased slightly for patients with easier access to care, while it remained relatively stable for patients with poor access to care. Conclusions During 2006–2015, 5-year survival was higher for HCC patients with easier access to care, probably reflecting progressive improvement in the effectiveness of health care services offered to these patients. Our linkage algorithm could provide valuable evidence to support healthcare decision-making in the context of the evolving epidemiology of hepatocellular carcinoma.
Collapse
Affiliation(s)
- Walter Mazzucco
- Department for Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy. .,Clinical Epidemiology and Cancer Registry Unit, Palermo University Hospital "P. Giaccone", Palermo, Italy. .,Division of Biostatistics and Epidemiology, Cincinnati Children's Hospital Medical Centre, Cincinnati, OH, USA. .,Department of Paediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
| | - Francesco Vitale
- Department for Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy.,Clinical Epidemiology and Cancer Registry Unit, Palermo University Hospital "P. Giaccone", Palermo, Italy
| | - Sergio Mazzola
- Clinical Epidemiology and Cancer Registry Unit, Palermo University Hospital "P. Giaccone", Palermo, Italy
| | - Rosalba Amodio
- Clinical Epidemiology and Cancer Registry Unit, Palermo University Hospital "P. Giaccone", Palermo, Italy
| | - Maurizio Zarcone
- Clinical Epidemiology and Cancer Registry Unit, Palermo University Hospital "P. Giaccone", Palermo, Italy
| | - Davide Alba
- Department for Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy
| | - Claudia Marotta
- Department for Health Promotion, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Palermo, Italy
| | | | - Claudia Allemani
- Cancer Survival Group, Department of Non-Communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK
| |
Collapse
|
8
|
Giglio RV, Carruba G, Cicero AF, Banach M, Patti AM, Nikolic D, Cocciadiferro L, Zarcone M, Montalto G, Stoian AP, Banerjee Y, Rizvi AA, Toth PP, Rizzo M. Pasta Supplemented with Opuntia ficus-indica Extract Improves Metabolic Parameters and Reduces Atherogenic Small Dense Low-Density Lipoproteins in Patients with Risk Factors for the Metabolic Syndrome: A Four-Week Intervention Study. Metabolites 2020; 10:metabo10110428. [PMID: 33114614 PMCID: PMC7694062 DOI: 10.3390/metabo10110428] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2020] [Revised: 10/19/2020] [Accepted: 10/20/2020] [Indexed: 12/24/2022] Open
Abstract
Food supplementation with Opuntia ficus-indica (OFI) has been associated with a significant reduction in total cholesterol, body fat, hyperglycemia and blood pressure. Since OFI may also have antioxidant and anti-atherogenic properties, we hypothesized that its supplementation might reduce atherogenic lipoproteins, including small, dense low-density lipoproteins (sdLDL). Forty-nine patients (13 men and 36 women, mean age: 56 ± 5 years) with one or two criteria for the metabolic syndrome weekly consumed 500 g of pasta supplemented with 3% OFI extract (30% of insoluble polysaccharides with high antioxidant power) for 1 month. The full LDL subclass profile was assessed by gel electrophoresis (Lipoprint, Quantimetrix, Redondo Beach, CA, USA). After 1 month of pasta supplementation, waist circumference (p = 0.0297), plasma glucose (p < 0.0001), triglycerides (p = 0.0137), plasma creatinine (p = 0.0244), urea and aspartate transaminase (p < 0.0001 for each) significantly decreased. A percentage increase in larger, less atherogenic LDL-1 (p = 0.0002), with a concomitant reduction in smaller, denser LDL-2 (p < 0.0001) and LDL-3 (p = 0.0004), were found. LDL-4 and-5 decreased, although not significantly. This is the first intervention study suggesting that pasta enriched with an OFI extract may have beneficial effects on some metabolic parameters and the LDL particle sizes, reducing atherogenic sdLDL. Future studies will help to establish if these findings impact cardiovascular outcomes.
Collapse
Affiliation(s)
- Rosaria Vincenza Giglio
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy; (R.V.G.); (A.M.P.); (G.M.); (M.R.)
| | - Giuseppe Carruba
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, 90127 Palermo, Italy; (G.C.); (L.C.); (M.Z.)
| | - Arrigo F.G. Cicero
- Medical and Surgical Sciences Department, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy;
| | - Maciej Banach
- Department of Hypertension, WAM University Hospital in Lodz, Medical University of Lodz, 90-419 Lodz, Poland;
- Polish Mother’s Memorial Hospital Research Institute (PMMHRI) in Lodz, 93-338 Lodz, Poland
| | - Angelo Maria Patti
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy; (R.V.G.); (A.M.P.); (G.M.); (M.R.)
| | - Dragana Nikolic
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy; (R.V.G.); (A.M.P.); (G.M.); (M.R.)
- Correspondence: ; Tel.: +39-091-655-4703
| | - Letizia Cocciadiferro
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, 90127 Palermo, Italy; (G.C.); (L.C.); (M.Z.)
| | - Maurizio Zarcone
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, 90127 Palermo, Italy; (G.C.); (L.C.); (M.Z.)
| | - Giuseppe Montalto
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy; (R.V.G.); (A.M.P.); (G.M.); (M.R.)
| | - Anca Pantea Stoian
- Department of Diabetes, Nutrition and Metabolic Diseases, Carol Davila University of Medicine and Pharmacy, 050474 Bucharest, Romania;
| | - Yajnavalka Banerjee
- Department of Biochemistry, Mohammed Bin Rashid University of Medicine and Health Sciences, 505055 Dubai, UAE;
| | - Ali A. Rizvi
- Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, SC 29203, USA;
- Division of Endocrinology, Metabolism, and Lipids, Emory University School of Medicine, Atlanta, GA 30322, USA
| | - Peter P. Toth
- CGH Medical Center, Sterling, IL 61081, USA;
- School of Medicine, University of Illinois, Peoria, IL 60612, USA
- School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA
| | - Manfredi Rizzo
- Department of Health Promotion Sciences Maternal and Infantile Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, 90127 Palermo, Italy; (R.V.G.); (A.M.P.); (G.M.); (M.R.)
- Division of Endocrinology, Diabetes and Metabolism, University of South Carolina School of Medicine, Columbia, SC 29203, USA;
| |
Collapse
|
9
|
Brusca I, Graci S, Barrale M, Cammilleri G, Zarcone M, Onida R, Costa A, Ferrantelli V, Buscemi MD, Uasuf CG, Gjomarkaj M, Vazzana M, La Chiusa SM, Iacolino G, Vitale F, Mazzucco W. Use of a comprehensive diagnostic algorithm for Anisakis allergy in a high seroprevalence Mediterranean setting. Eur Ann Allergy Clin Immunol 2019; 52:131-141. [PMID: 31668056 DOI: 10.23822/eurannaci.1764-1489.118] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Summary Background.Diagnosis of anisakis allergy (AA) is based on the skin prick test (SPT) and specific IgE (sIgE) determination. Anyway, false positivity cases are due to cross reactivity with numerous allergens. The aim of the study was to evaluate the reliability of a comprehensive diagnostic algorithm for the AA. Methods.An observational study was conducted on a sample of consecutive subjects accessing the allergology outpatient ambulatories of two hospitals located in Western Sicily. All the recruited outpatients were tested by Skin Prick Test performed using anisakis extracts by ALK-Abellò (Madrid, Spain). Specific IgE dosage for anisakis extracts was then performed by using ImmunoCAP250 (Immunodiagnostics Uppsala, Sweden). Consequently, outpatients who tested positive to first line tests underwent sIgE testing for ascaris and tropomyosin. Lastly, outpatients positive to the first line were invited to be further tested by basophil activation test (BAT) by using Flow CAST kit and anisakis commercial extract (Bühlmann Laboratories AG, Schönenbuch, Switzerland), as confirmatory analysis. Results.One hundred and eleven outpatients with an anamnesis suggestive of sensitization to anisakis (AS) and 466 subjects with chronic urticaria (CU) were recruited in the study. Of these, 22 with AS and 41 with CU showed a sensitization to anisakis allergens. The diagnostic algorithm revealed that 8.8% of outpatients who tested positive to sIgE determination were affected by CU, while 82.5% of all the sIgE positivity was related to cross-reactivity. Overall, a genuine anisakis seroprevalence of 2.3% was documented. Within a sub-sample of 15 subjects with clinical symptoms related to AA, n. 8 showed a real positivity after BAT. A greater response to A. pegreffii allergens as compared to A. simplex was reported. Conclusions.Our preliminary findings support the high clinical specificity of BAT for AA diagnosis, suggesting implementing this method in a comprehensive diagnostic algorithm.
Collapse
Affiliation(s)
- I Brusca
- Clinical Pathology Buccheri La Ferla Hospital, Palermo, Italy
| | - S Graci
- National Reference Centre for Anisakiasis, Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italy
| | - M Barrale
- Clinical Pathology Buccheri La Ferla Hospital, Palermo, Italy
| | - G Cammilleri
- National Reference Centre for Anisakiasis, Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italy
| | - M Zarcone
- Department of Science for Health Promotion and Mother to Child Care G. D'Alessandro, University of Palermo, Palermo, Italy. Clinical Epidemiology and Cancer Registry Unit, P. Giaccone University Hospital, Palermo, Italy
| | - R Onida
- Clinical Pathology Buccheri La Ferla Hospital, Palermo, Italy
| | - A Costa
- National Reference Centre for Anisakiasis, Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italy
| | - V Ferrantelli
- National Reference Centre for Anisakiasis, Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italy
| | - M D Buscemi
- National Reference Centre for Anisakiasis, Istituto Zooprofilattico Sperimentale della Sicilia A. Mirri, Palermo, Italy
| | - C G Uasuf
- Allergy Diseases Center G. Bonsignore, Institute of Biomedicine and Molecular Immunology A. Monroy (IBIM), National Research Council (CNR), Palermo, Italy
| | - M Gjomarkaj
- Allergy Diseases Center G. Bonsignore, Institute of Biomedicine and Molecular Immunology A. Monroy (IBIM), National Research Council (CNR), Palermo, Italy
| | - M Vazzana
- STEBICEF Department, University of Palermo, Palermo, Italy
| | - S M La Chiusa
- Clinical Pathology Buccheri La Ferla Hospital, Palermo, Italy
| | - G Iacolino
- Clinical Pathology Buccheri La Ferla Hospital, Palermo, Italy
| | - F Vitale
- Department of Science for Health Promotion and Mother to Child Care G. D'Alessandro, University of Palermo, Palermo, Italy. Clinical Epidemiology and Cancer Registry Unit, P. Giaccone University Hospital, Palermo, Italy
| | - W Mazzucco
- Department of Science for Health Promotion and Mother to Child Care G. D'Alessandro, University of Palermo, Palermo, Italy. Clinical Epidemiology and Cancer Registry Unit, P. Giaccone University Hospital, Palermo, Italy
| |
Collapse
|
10
|
Mazzucco W, Cusimano R, Marotta C, Zarcone M, Mazzola S, Gaglio V, Casuccio A, Vitale F. Funnel plots and choropleth maps in cancer risk communication: a Delphi study. Ann Ig 2019; 31:244-251. [PMID: 31069369 DOI: 10.7416/ai.2019.2287] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
BACKGROUND In the last decades, the issues related to health risk communication to stakeholders and citizens involving health care practitioners and local political authorities have been increasingly debated. The study evaluated an alternative strategy to communicate cancer risk to local communities, involving an expert panel of public health operators in comparing two different graphic tools, Funnel Plot and Choropleth map. STUDY DESIGN A Delphi method process was implemented to achieve a unified consensus on an expert panel of public health operators with regard to weaknesses and strengths of the Funnel Plot and the Choropleth map as tools for cancer risk communication to local communities and other stakeholders. METHODS Participants were asked to score the efficacy of the two tools using a scale. Six properties were explored through two consecutive consensus rounds. Scales were used to calculate frequencies and the content validity ratio for each domain within the consensus rounds. RESULTS After the two consecutive rounds, participants expressed their preference in favour of the Choropleth map for its ability to define the spatial location of the risk and to locate any potential cluster, while reaching a consensus with regard to the Funnel Plot properties to identify hot spots, displaying the scope of the phenomenon under investigation, and to show the precision of estimates and communicating the significance of estimates. CONCLUSIONS The Delphi process allowed us to conclude that Funnel Plot could be used as a complement to the current and commonly used graphical and visual formats to effectively communicate cancer epidemiological data to communities and local authorities, representing a useful tool for empowering the general population.
Collapse
Affiliation(s)
- W Mazzucco
- Palermo Province Cancer Registry, Palermo, Italy - Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, Italy
| | - R Cusimano
- Palermo Province Cancer Registry, Palermo, Italy - Local Health Unit 6, Department of Prevention, Palermo, Italy
| | - C Marotta
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, Italy
| | - M Zarcone
- Palermo Province Cancer Registry, Palermo, Italy - Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" Teaching Hospital, Palermo, Italy
| | - S Mazzola
- Palermo Province Cancer Registry, Palermo, Italy - Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" Teaching Hospital, Palermo, Italy
| | - V Gaglio
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, Italy
| | - A Casuccio
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, Italy
| | - F Vitale
- Palermo Province Cancer Registry, Palermo, Italy - Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, Italy - Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" Teaching Hospital, Palermo, Italy
| |
Collapse
|
11
|
Francavilla VC, Vitale F, Ciaccio M, Bongiovanni T, Marotta C, Caldarella R, Todaro L, Zarcone M, Muratore R, Bellia C, Francavilla G, Mazzucco W. Use of Saliva in Alternative to Serum Sampling to Monitor Biomarkers Modifications in Professional Soccer Players. Front Physiol 2018; 9:1828. [PMID: 30618836 PMCID: PMC6306404 DOI: 10.3389/fphys.2018.01828] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Accepted: 12/06/2018] [Indexed: 01/05/2023] Open
Abstract
We aimed to investigate the correlation between serum and salivary concentrations of steroid hormones and IgA, and the variation in concentrations of these biomarkers, across a soccer competitive season in a sample of players playing for an Italian major League team. Thirty-five elite male soccer players were recruited and assessed for salivary hormones (cortisol, testosterone, T/C‰ and DHEA-S) and IgA at three different time-points: (t1) after the pre-season period and 16 official matches played; (t2) after a winter break and three official matches played; (t3) 2 days after the final match of the championship and 19 matches played. Players were also tested for blood biomarkers (ser-C, ser-T, ser-T/C‰, ser-IgA, ACTH) at two detection times (t1 and t3). Blood samples were collected immediately after saliva sampling. The Spearman’s rank correlation was used to explore the correlation between blood and salivary concentrations of cortisol, free testosterone and IgA in the different time points. One-way ANOVA and permutation test were performed to explore changes by time of hormones and IgA concentrations over the competitive season. We documented a positive correlation between serum and saliva concentrations for Cortisol at t1 (+58.2%; p-value = 0.002) and t3 (+54.2%; p-value = 0.018) and for Testosterone at t1 (+42.0%; p-value = 0.033). Moreover, a positive variation was documented across the season (D = t3–t1) for Cortisol (D = +6.83; SEM = ±2.70; Var% = +37.6; p-value = 0.032), Testosterone (D = +0.33; SEM = ±0.07; Var% = +27.3; p-value = 0.002) and DHEA-S (D = +44.48; SEM = ±18.54; Var% = +82.0; p-value = 0.042), while a decrease of sal-T/C ratio and no variation in salivary IgA concentrations were reported. In conclusion, our findings support for experimental use of saliva samples to monitor steroid hormones modifications in professional soccer players across a competitive season.
Collapse
Affiliation(s)
| | - Francesco Vitale
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro," University of Palermo, Palermo, Italy
| | - Marcello Ciaccio
- Department of Laboratory Medicine, "P. Giaccone" University Hospital, Palermo, Italy
| | - Tindaro Bongiovanni
- Nutrition, Hydration & Body Composition Department, Parma Calcio 1913, Parma, Italy
| | - Claudia Marotta
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro," University of Palermo, Palermo, Italy
| | - Rosalia Caldarella
- Complex Unit of Laboratory Medicine, "P. Giaccone" University Hospital, Palermo, Italy
| | | | - Maurizio Zarcone
- Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" University Hospital, Palermo, Italy
| | - Roberto Muratore
- Complex Unit of Laboratory Medicine, "P. Giaccone" University Hospital, Palermo, Italy
| | - Chiara Bellia
- Department of Laboratory Medicine, "P. Giaccone" University Hospital, Palermo, Italy
| | - Giuseppe Francavilla
- Department of Surgical, Anatomical and Oncological Disciplines, University of Palermo, Palermo, Italy
| | - Walter Mazzucco
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro," University of Palermo, Palermo, Italy
| |
Collapse
|
12
|
Mazzucco W, Cusimano R, Mazzola S, Rudisi G, Zarcone M, Marotta C, Graziano G, D'Angelo P, Vitale F. Comparison of paediatric cancers outcomes between Palermo Province (Sicily) and Southern Europe. Eur J Public Health 2018. [DOI: 10.1093/eurpub/cky214.247] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
| | - R Cusimano
- Local Health Agency Palermo, Palermo, Italy
| | - S Mazzola
- Palermo Province Cancer Registry, Palermo, Italy
| | - G Rudisi
- Local Health Agency Palermo, Palermo, Italy
| | - M Zarcone
- Palermo Province Cancer Registry, Palermo, Italy
| | - C Marotta
- University of Palermo, Palermo, Italy
| | | | | | - F Vitale
- University of Palermo, Palermo, Italy
| |
Collapse
|
13
|
Mazzucco W, Cusimano R, Mazzola S, Rudisi G, Zarcone M, Marotta C, Graziano G, D'Angelo P, Vitale F. Childhood and Adolescence Cancers in the Palermo Province (Southern Italy): Ten Years (2003⁻2012) of Epidemiological Surveillance. Int J Environ Res Public Health 2018; 15:E1344. [PMID: 29949937 PMCID: PMC6069060 DOI: 10.3390/ijerph15071344] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/07/2018] [Revised: 06/16/2018] [Accepted: 06/23/2018] [Indexed: 02/06/2023]
Abstract
Italy has one of the highest paediatric cancer incidence rates in Europe. We compared cancer incidence and survival rates in children (0⁻14 years) and adolescents (15⁻19 years) residing in Palermo Province (PP) with statistics derived from Italian and European surveillance systems. We included all incident cancer cases, malignant tumours and non-malignant neoplasm of central nervous system (benign and uncertain whether malignant or benign), detected in children and adolescents by the Palermo Province Cancer Registry (PPCR) between 2003 and 2012. A jointpoint regression model was applied. Annual Average Percentage Changes were calculated. The Besag⁻York-Mollie model was used to detect any cluster. The 5-year survival analysis was computed using Kaplan-Meier and actuarial methods. We identified 555 paediatric cancer incident cases (90% “malignant tumours”). No difference in incidence rates was highlighted between PPCR and Italy 26 registries and between PPCR and Southern Europe. No jointpoint or significant trend was identified and no cluster was detected. The 5-year overall survival didn’t differ between PP and the Italian AIRTUM pool. A borderline higher statistically significant survival was observed in age-group 1⁻4 when comparing PPCR to EUROCARE-5. The epidemiological surveillance documented in the PP was a paediatric cancer burden in line with Italy and southern Europe. The study supports the supplementary role of general population-based cancer registries to provide paediatric cancer surveillance of local communities.
Collapse
Affiliation(s)
- Walter Mazzucco
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, via del Vespro, 133 Palermo, Italy.
- Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" University Hospital, via del Vespro, 133 Palermo, Italy.
| | | | - Sergio Mazzola
- Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" University Hospital, via del Vespro, 133 Palermo, Italy.
| | - Giuseppa Rudisi
- Local Health Unit 6, via Giacomo Cusmano, 24 Palermo, Italy.
| | - Maurizio Zarcone
- Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" University Hospital, via del Vespro, 133 Palermo, Italy.
| | - Claudia Marotta
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, via del Vespro, 133 Palermo, Italy.
| | - Giorgio Graziano
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, via del Vespro, 133 Palermo, Italy.
| | - Paolo D'Angelo
- Paediatric Haematology and Oncology Unit, ARNAS "Civico-Di Cristina-Benfratelli", Piazza Nicola Leotta, 4 Palermo, Italy.
| | - Francesco Vitale
- Department of Science for Health Promotion and Mother to Child Care "G. D'Alessandro", University of Palermo, via del Vespro, 133 Palermo, Italy.
- Clinical Epidemiology and Cancer Registry Unit, "P. Giaccone" University Hospital, via del Vespro, 133 Palermo, Italy.
| |
Collapse
|
14
|
Vercelli M, Lillini R, Quaglia A, Capocaccia R, Vercelli M, Lillini L, Quaglia A, Capocaccia R, De Angelis R, Gatta G, Tagliabue G, Pannozzo F, Ramazzotti V, Fusco M, Cilia S, De Felice E, Vattiato R, Senatore R, Zucchetto A, Buzzoni C, Tognazzo S, Bellù F, Piffer S, Cusimano R, Zarcone M, Cirilli C, Stracci F, Ferretti S, Cesaraccio R, Rosso S, Giacomin A, Cuccaro F, Michiara M. Italian Regional Health System Structure and Expected Cancer Survival. Tumori Journal 2018. [DOI: 10.1177/1636.17892] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
- Marina Vercelli
- Liguria Region Cancer Registry, Descriptive Epidemiology Unit, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa
- Department of Health Sciences, University of Genoa, Genoa
| | - Roberto Lillini
- Liguria Region Cancer Registry, Descriptive Epidemiology Unit, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa
- National Center of Epidemiology, Surveillance and Promotion of Health, National Institute of Health, Rome
- “Vita & Salute” San Raffaele University, Milan, Italy
| | - Alberto Quaglia
- Liguria Region Cancer Registry, Descriptive Epidemiology Unit, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa
| | - Riccardo Capocaccia
- Liguria Region Cancer Registry, Descriptive Epidemiology Unit, IRCCS Azienda Ospedaliera Universitaria San Martino – IST Istituto Nazionale per la Ricerca sul Cancro, Genoa
- National Center of Epidemiology, Surveillance and Promotion of Health, National Institute of Health, Rome
| | - M Vercelli
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - L Lillini
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - A Quaglia
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - R Capocaccia
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - R De Angelis
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - G Gatta
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - G Tagliabue
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - F Pannozzo
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - V Ramazzotti
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - M Fusco
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - S Cilia
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - E De Felice
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - R Vattiato
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - R Senatore
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - A Zucchetto
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - C Buzzoni
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - S Tognazzo
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - F Bellù
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - S Piffer
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - R Cusimano
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - M Zarcone
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - C Cirilli
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - F Stracci
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - S Ferretti
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - R Cesaraccio
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - S Rosso
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - A Giacomin
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - F Cuccaro
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | - M Michiara
- Registro Tumori del Veneto, Istituto Oncologico Veneto IRCCS
| | | |
Collapse
|
15
|
Mazzucco W, Cusimano R, Zarcone M, Mazzola S, Vitale F. Funnel plots and choropleth maps in cancer risk communication: a comparison of tools for disseminating population-based incidence data to stakeholders. BMJ Open 2017; 7:e011502. [PMID: 28363917 PMCID: PMC5387987 DOI: 10.1136/bmjopen-2016-011502] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/03/2016] [Revised: 10/28/2016] [Accepted: 12/22/2016] [Indexed: 01/01/2023] Open
Abstract
BACKGROUND Population-based cancer registries provide epidemiological cancer information, but the indicators are often too complex to be interpreted by local authorities and communities, due to numeracy and literacy limitations. The aim of this paper is to compare the commonly used visual formats to funnel plots to enable local public health authorities and communities to access valid and understandable cancer incidence data obtained at the municipal level. METHODS A funnel plot representation of standardised incidence ratio (SIR) was generated for the 82 municipalities of the Palermo Province with the 2003-2011 data from the Palermo Province Cancer Registry (Sicily, Italy). The properties of the funnel plot and choropleth map methodologies were compared within the context of disseminating epidemiological data to stakeholders. RESULTS The SIRs of all the municipalities remained within the control limits, except for Palermo city area (SIR=1.12), which was sited outside the upper control limit line of 99.8%. The Palermo Province SIRs funnel plot representation was congruent with the choropleth map generated from the same data, but the former resulted more informative as shown by the comparisons of the weaknesses and strengths of the 2 visual formats. CONCLUSIONS Funnel plot should be used as a complementary valuable tool to communicate epidemiological data of cancer registries to communities and local authorities, visually conveying an efficient and simple way to interpret cancer incidence data.
Collapse
Affiliation(s)
- Walter Mazzucco
- Registro Tumori di Palermo e Provincia, University of Palermo, Palermo, Italy
- Dipartimento Scienze Promozione della Salute e Materno Infantile “G. D'Alessandro”, Sezione di Igiene, University of Palermo, Palermo, Italy
| | - Rosanna Cusimano
- Registro Tumori di Palermo e Provincia, University of Palermo, Palermo, Italy
- Azienda Sanitaria Provinciale 6 di Palermo—Dipartimento di Prevenzione, Palermo, Italy
| | - Maurizio Zarcone
- Registro Tumori di Palermo e Provincia, University of Palermo, Palermo, Italy
- Unità Operativa Complessa di Epidemiologia Clinica con Registro Tumori, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”, Palermo, Italy
| | - Sergio Mazzola
- Registro Tumori di Palermo e Provincia, University of Palermo, Palermo, Italy
- Unità Operativa Complessa di Epidemiologia Clinica con Registro Tumori, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”, Palermo, Italy
| | - Francesco Vitale
- Registro Tumori di Palermo e Provincia, University of Palermo, Palermo, Italy
- Dipartimento Scienze Promozione della Salute e Materno Infantile “G. D'Alessandro”, Sezione di Igiene, University of Palermo, Palermo, Italy
- Unità Operativa Complessa di Epidemiologia Clinica con Registro Tumori, Azienda Ospedaliera Universitaria Policlinico “Paolo Giaccone”, Palermo, Italy
| |
Collapse
|
16
|
Scerrino G, Attard M, Lo Piccolo C, Attard A, Melfa GI, Raspanti C, Zarcone M, Bonventre S, Mazzola S, Gulotta G. The coexistence of primary hyperparathyroidism and thyroid nodules: should the preoperative work-up of the parathyroid and the thyroid diseases be specifically adjusted? G Chir 2016; 37:123-129. [PMID: 27734796 DOI: 10.11138/gchir/2016.37.3.123] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
INTRODUCTION AND OBJECTIVES Primary hyperparathyroidism (PHPT) can be found in concomitance with thyroid disease (TD) in a high frequency of cases. In this context the diagnostic exams for localizing the enlarged parathyroid(s) gland(s) could be less reliable or nonconclusive. Moreover, the thyroid carcinoma seems to be more frequent compared to that isolated thyroid desease and, therefore, carefully investigated. The main goal of the present study is to evaluate which diagnostic tool (US, MIBI) is more reliable for localizing the site of the PTH hypersecretion and to confirm if it is always advantageous a combination of both exams. Besides, we evaluated the incidence of thyroid carcinoma in our series of patients. PATIENTS AND METHODS A review of available data of 73 patients who underwent total thyroidectomy + parathyroidectomy from 2003 and 2014 was performed. The preoperative workup included systematically US and MIBI whose results were considered true positive when at least the side (left/right) of the parathyroid affected were concordant with the surgical report, settled as the gold standard, according to the Cox nonnested model. The connection between the diagnostic results of US versus MIBI was calculated with the Cohen K index for evaluating their overlap. The average of the thyroid carcinoma were also calculated. RESULTS The difference between respectively US versus surgical report (p value=0.73) and MIBI versus surgical report (p value=0.81) were not significant. The low Cohen K index showed that both US and MIBI are complementary. In 23 patients (32,9%) a thyroid carcinoma was found. CONCLUSIONS The association of MIBI and neck US is mandatory in the first evaluation of patients undergoing thyroidectomy and parathyroid excision simultaneously. The high prevalence of thyroid carcinoma in this specific context suggests a more aggressive diagnostic and surgical behaviour.
Collapse
|
17
|
Carruba G, Cocciadiferro L, Di Cristina A, Granata OM, Dolcemascolo C, Campisi I, Zarcone M, Cinquegrani M, Traina A. Nutrition, aging and cancer: lessons from dietary intervention studies. Immun Ageing 2016; 13:13. [PMID: 27057203 PMCID: PMC4823849 DOI: 10.1186/s12979-016-0069-9] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/05/2016] [Accepted: 03/30/2016] [Indexed: 11/10/2022]
Abstract
There is convincing epidemiological and clinical evidence that, independent of aging, lifestyle and, notably, nutrition are associated with development or progression of major human cancers, including breast, prostate, colorectal tumors, and an increasingly large collection of diet-related cancers. Mechanisms underlying this association are mostly related to the distinct epigenetic effects of different dietary patterns. In this context, Mediterranean diet has been reported to significantly reduce mortality rates for various chronic illnesses, including cardiovascular diseases, neurodegenerative diseases and cancer. Although many observational studies have supported this evidence, dietary intervention studies using a Mediterranean dietary pattern or its selected food components are still limited and affected by a rather large variability in characteristics of study subjects, type and length of intervention, selected end-points and statistical analysis. Here we review data of two of our intervention studies, the MeDiet study and the DiMeSa project, aimed at assessing the effects of traditional Mediterranean diet and/or its component(s) on a large panel of both plasma and urine biomarkers. Both published and unpublished results are presented and discussed.
Collapse
Affiliation(s)
- Giuseppe Carruba
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, Palermo, Italy
| | | | | | - Orazia M Granata
- Clinical Pathology, "G. DI Cristina" Pediatric Hospital ARNAS-Civico Di Cristina e Benfratelli, Palermo, Italy
| | - Cecilia Dolcemascolo
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, Palermo, Italy
| | - Ildegarda Campisi
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, Palermo, Italy
| | - Maurizio Zarcone
- Division of Research and Internationalization, ARNAS-Civico Di Cristina e Benfratelli, Palermo, Italy
| | | | - Adele Traina
- The Diana Project, National Cancer Institute, Milan, Italy
| |
Collapse
|
18
|
Accardi G, Aiello A, Gargano V, Gambino CM, Caracappa S, Marineo S, Vesco G, Carru C, Zinellu A, Zarcone M, Caruso C, Candore G. Nutraceutical effects of table green olives: a pilot study with Nocellara del Belice olives. Immun Ageing 2016; 13:11. [PMID: 27053940 PMCID: PMC4822236 DOI: 10.1186/s12979-016-0067-y] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/11/2016] [Accepted: 03/30/2016] [Indexed: 11/10/2022]
Abstract
Background The aim of this study was to analyse the nutraceutical properties of table green olives Nocellara del Belice, a traditional Mediterranean food. The Mediterranean Diet has as key elements olives and extra virgin olive oil, common to all Mediterranean countries. Olive oil is the main source of fat and can modulate oxidative stress and inflammation, whereas little is known about the role of olives. Moreover, emerging evidences underline the association between gut microbiota and food as the basis of many phenomena that affect health and delay or avoid the onset of some age-related chronic diseases. Methods In order to show if table green olives have nutraceutical properties and/or probiotic effect, we performed a nutritional intervention, administering to 25 healthy subjects (mean age 38,3), 12 table green olives/day for 30 days. We carried out anthropometric, biochemical, oxidative stress and cytokines analyses at the beginning of the study and at the end. Moreover, we also collected fecal samples to investigate about the possible variation of concentration of Lactobacilli, after the olives consumption. Result Our results showed a significant variation of one molecule related to oxidative stress, malondialdehyde, confirming that Nocellara del Belice green olives could have an anti-oxidant effect. In addition, the level of interleukin-6 decreased significantly, demonstrating how this food could be able to modulate the inflammatory response. Moreover, it is noteworthy the reduction of fat mass with an increase of muscle mass, suggesting a possible effect on long time assumption of table olives on body mass variation. No statistically significant differences were observed in the amount of Lactobacilli, although a trend towards an increased concentration of them at the end of the intervention could be related to the nutraceutical effects of olives. Conclusion These preliminary results suggest a possible nutraceutical effect of daily consumption of green table olives Nocellara del Belice. To best of our knowledge, this is the first study performed to assess nutraceutical properties of this food. Of course, it is necessary to verify the data in a larger sample of individuals to confirm their role as nutraceuticals.
Collapse
Affiliation(s)
- Giulia Accardi
- Sezione di Patologia generale del Dipartimento di Biopatologia e Biotecnologie Mediche (DIBIMED), Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy
| | - Anna Aiello
- Sezione di Patologia generale del Dipartimento di Biopatologia e Biotecnologie Mediche (DIBIMED), Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy
| | - Valeria Gargano
- Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi 3, 90129 Palermo, Italy
| | - Caterina Maria Gambino
- Sezione di Patologia generale del Dipartimento di Biopatologia e Biotecnologie Mediche (DIBIMED), Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy
| | - Santo Caracappa
- Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi 3, 90129 Palermo, Italy
| | - Sandra Marineo
- Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi 3, 90129 Palermo, Italy
| | - Gesualdo Vesco
- Istituto Zooprofilattico Sperimentale della Sicilia, Via Gino Marinuzzi 3, 90129 Palermo, Italy
| | - Ciriaco Carru
- Dipartimento di Scienze Biomediche, Università di Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy
| | - Angelo Zinellu
- Dipartimento di Scienze Biomediche, Università di Sassari, Viale San Pietro 43/b, 07100 Sassari, Italy
| | - Maurizio Zarcone
- UOC Epidemiologia Clinica con registro tumori di Palermo e provincia, AOUP "Paolo Giaccone", Palermo, c/o Dipartimento di Scienze per la promozione della salute e materno infantile "G. D'Alessandro", Università di Palermo, Via del Vespro 133, 90131 Palermo, Italy
| | - Calogero Caruso
- Sezione di Patologia generale del Dipartimento di Biopatologia e Biotecnologie Mediche (DIBIMED), Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy
| | - Giuseppina Candore
- Sezione di Patologia generale del Dipartimento di Biopatologia e Biotecnologie Mediche (DIBIMED), Università di Palermo, Corso Tukory 211, 90134 Palermo, Italy
| |
Collapse
|
19
|
Marcos-Gragera R, Mallone S, Kiemeney LA, Vilardell L, Malats N, Allory Y, Sant M, Hackl M, Zielonke N, Oberaigner W, Van Eycken E, Henau K, Valerianova Z, Dimitrova N, Sekerija M, Zvolský M, Dušek L, Storm H, Engholm G, Mägi M, Aareleid T, Malila N, Seppä K, Velten M, Troussard X, Bouvier V, Launoy G, Guizard A, Faivre J, M. Bouvier A, Arveux P, Maynadié M, Woronoff A, Robaszkiewicz M, Baldi I, Monnereau A, Tretarre B, Bossard N, Belot A, Colonna M, Molinié F, Bara S, Schvartz C, Lapôtre-Ledoux B, Grosclaude P, Meyer M, Stabenow R, Luttmann S, Eberle A, Brenner H, Nennecke A, Engel J, Schubert-Fritschle G, Kieschke J, Heidrich J, Holleczek B, Katalinic A, Jónasson J, Tryggvadóttir L, Comber H, Mazzoleni G, Bulatko A, Buzzoni C, Giacomin A, Sutera Sardo A, Mazzei A, Ferretti S, Crocetti E, Manneschi G, Gatta G, Sant M, Amash H, Amati C, Baili P, Berrino F, Bonfarnuzzo S, Botta L, Di Salvo F, Foschi R, Margutti C, Meneghini E, Minicozzi P, Trama A, Serraino D, Zucchetto A, De Angelis R, Caldora M, Capocaccia R, Carrani E, Francisci S, Mallone S, Pierannunzio D, Roazzi P, Rossi S, Santaquilani M, Tavilla A, Pannozzo F, Busco S, Bonelli L, Vercelli M, Gennaro V, Ricci P, Autelitano M, Randi G, Ponz De Leon M, Marchesi C, Cirilli C, Fusco M, Vitale M, Usala M, Traina A, Zarcone M, Vitale F, Cusimano R, Michiara M, Tumino R, Giorgi Rossi P, Vicentini M, Falcini F, Iannelli A, Sechi O, Cesaraccio R, Piffer S, Madeddu A, Tisano F, Maspero S, Fanetti A, Zanetti R, Rosso S, Candela P, Scuderi T, Stracci F, Rocca A, Tagliabue G, Contiero P, Dei Tos A, Tognazzo S, Pildava S, Smailyte G, Calleja N, Micallef R, Johannesen T, Rachtan J, Gózdz S, Mezyk R, Blaszczyk J, Kepska K, Bielska-Lasota M, Forjaz de Lacerda G, Bento M, Antunes L, Miranda A, Mayer-da-Silva A, Nicula F, Coza D, Safaei Diba C, Primic-Zakelj M, Almar E, Mateos A, Errezola M, Larrañaga N, Torrella-Ramos A, Díaz García J, Marcos-Navarro A, Marcos-Gragera R, Vilardell L, Sanchez M, Molina E, Navarro C, Chirlaque M, Moreno-Iribas C, Ardanaz E, Galceran J, Carulla M, Lambe M, Khan S, Mousavi M, Bouchardy C, Usel M, Ess S, Frick H, Lorez M, Ess S, Herrmann C, Bordoni A, Spitale A, Konzelmann I, Visser O, Aben K, Coleman M, Allemani C, Rachet B, Verne J, Easey N, Lawrence G, Moran T, Rashbass J, Roche M, Wilkinson J, Gavin A, Fitzpatrick D, Brewster D, Huws D, White C, Otter R. Urinary tract cancer survival in Europe 1999–2007: Results of the population-based study EUROCARE-5. Eur J Cancer 2015; 51:2217-2230. [DOI: 10.1016/j.ejca.2015.07.028] [Citation(s) in RCA: 43] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2015] [Revised: 07/02/2015] [Accepted: 07/20/2015] [Indexed: 12/22/2022]
|
20
|
Bruno E, Gargano G, Villarini A, Traina A, Johansson H, Mano MP, Santucci De Magistris M, Simeoni M, Consolaro E, Mercandino A, Barbero M, Galasso R, Bassi MC, Zarcone M, Zagallo E, Venturelli E, Bellegotti M, Berrino F, Pasanisi P. Adherence to WCRF/AICR cancer prevention recommendations and metabolic syndrome in breast cancer patients. Int J Cancer 2015; 138:237-44. [PMID: 26175188 DOI: 10.1002/ijc.29689] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2015] [Revised: 06/18/2015] [Accepted: 07/01/2015] [Indexed: 12/18/2022]
Abstract
Metabolic syndrome (MetS), conventionally defined by the presence of at least three out of five dismetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol and high plasma glucose and triglycerides), has been associated with both breast cancer (BC) incidence and prognosis. We investigated the association between the prevalence of MetS and a score of adherence to the World Cancer Research Fund (WCRF) and American Institute for Cancer Research (AICR) recommendations for the prevention of cancer in a cross-sectional study of BC patients. The DIet and ANdrogen-5 study (DIANA-5) for the prevention of BC recurrences recruited 2092 early stage BC survivors aged 35-70. At recruitment, all women completed a 24-hour food frequency and physical activity diary on their consumption and activity of the previous day. Using these diaries we created a score of adherence to five relevant WCRF/AICR recommendations. The prevalence ratios (PRs) and 95% confidence intervals (CIs) of MetS associated with the number of recommendations met were estimated using a binomial regression model. The adjusted PRs of MetS decreased with increasing number of recommendations met (p < 0.001). Meeting all the five recommendations versus meeting none or only one was significantly associated with a 57% lower MetS prevalence (95% CI 0.35-0.73). Our results suggest that adherence to WCRF/AICR recommendations is a major determinant of MetS and may have a clinical impact.
Collapse
Affiliation(s)
- Eleonora Bruno
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| | - Giuliana Gargano
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| | - Anna Villarini
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| | - Adele Traina
- Department of Oncology, A.R.N.A.S Ospedali Civico E Benfratelli G. Di Cristina E M. Ascoli, Palermo, Italy
| | - Harriet Johansson
- Division of Chemoprevention and Genetics, European Institute Of Oncology, Milan, Italy
| | - Maria Piera Mano
- Dipartimento Scienze Chirurgiche, Study University, Turin, Italy.,S.C. Epidemiologia Dei Tumori, AOU Città Della Salute E Della Scienza, CPO Piemonte, Turin, Italy
| | | | - Milena Simeoni
- Associazione LUMEN, San Pietro In Cerro (Piacenza), Italy
| | | | | | | | - Rocco Galasso
- Biostatistics and Cancer Registry, Unit Of Clinical Epidemiology, IRCCS Centro Di Riferimento Oncologico Di Basilicata, Rionero In Vulture (Potenza), Italy
| | | | - Maurizio Zarcone
- Department of Oncology, A.R.N.A.S Ospedali Civico E Benfratelli G. Di Cristina E M. Ascoli, Palermo, Italy
| | - Emanuela Zagallo
- Division of Chemoprevention and Genetics, European Institute Of Oncology, Milan, Italy
| | - Elisabetta Venturelli
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| | - Manuela Bellegotti
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| | - Franco Berrino
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| | - Patrizia Pasanisi
- Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale Dei Tumori, Milan, Italy
| |
Collapse
|
21
|
Berrino F, Villarini A, Traina A, Bonanni B, Panico S, Mano MP, Mercandino A, Galasso R, Barbero M, Simeoni M, Bassi MC, Consolaro E, Johansson H, Zarcone M, Bruno E, Gargano G, Venturelli E, Pasanisi P. Metabolic syndrome and breast cancer prognosis. Breast Cancer Res Treat 2014; 147:159-65. [PMID: 25104441 DOI: 10.1007/s10549-014-3076-6] [Citation(s) in RCA: 78] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2014] [Accepted: 07/21/2014] [Indexed: 01/06/2023]
Abstract
Metabolic syndrome (MS), conventionally defined by the presence of at least three out of five dysmetabolic traits (abdominal obesity, hypertension, low plasma HDL-cholesterol, high plasma glucose and high triglycerides), has been associated with an increased risk of several age-related chronic diseases, including breast cancer (BC). This may have prognostic implications for BC survivors. 2,092 early stage BC survivors aged 35-70, recruited in eleven Italian centres 0-5 years after surgical treatment (1.74 years on average), were followed-up over 2.8 years on average for additional BC-related events, including BC-specific mortality, distant metastasis, local recurrences and contralateral BC. At recruitment, 20 % of the patients had MS. Logistic regression models were carried out to generate OR and 95 % confidence intervals (CI) for new BC events associated with MS, adjusting for baseline pathological prognostic factors. New BC events occurred in 164 patients, including 89 distant metastases. The adjusted ORs for women with MS versus women without any MS traits were 2.17 (CI 1.31-3.60) overall, and 2.45 (CI 1.24-4.82) for distant metastasis. The OR of new BC events for women with only one or two MS traits was 1.40 (CI 0.91-2.16). All MS traits were positively associated with new BC events, and significantly so for low HDL and high triglycerides. MS is an important prognostic factor in BC. As MS is reversible through lifestyle changes, interventions to decrease MS traits in BC patients should be implemented in BC clinics.
Collapse
Affiliation(s)
- Franco Berrino
- Epidemiology & Prevention Unit, Department of Preventive & Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian, 1, 20133, Milan, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
22
|
Minicozzi P, Berrino F, Sebastiani F, Falcini F, Vattiato R, Cioccoloni F, Calagreti G, Fusco M, Vitale MF, Tumino R, Sigona A, Budroni M, Cesaraccio R, Candela G, Scuderi T, Zarcone M, Campisi I, Sant M. High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease. Eur J Cancer 2013; 49:3881-8. [PMID: 24011933 DOI: 10.1016/j.ejca.2013.08.004] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2013] [Revised: 07/06/2013] [Accepted: 08/08/2013] [Indexed: 12/19/2022]
Abstract
PURPOSE We investigated the effect of fasting blood glucose and body mass index (BMI) at diagnosis on risk of breast cancer death for cases diagnosed in five Italian cancer registries in 2003-2005 and followed up to the end of 2008. METHODS For 1607 Italian women (≥15 years) with information on BMI or blood glucose or diabetes, we analysed the risk of breast cancer death in relation to glucose tertiles (≤84.0, 84.1-94.0, >94.0 mg/dl) plus diabetic and unspecified categories; BMI tertiles (≤23.4, 23.5-27.3, >27.3 kg/m(2), unspecified), stage (T1-3N0M0, T1-3N+M0 plus T4anyNM0, M1, unspecified), oestrogen (ER) and progesterone (PR) status (ER+PR+, ER-PR-, ER and PR unspecified, other), age, chemotherapy and endocrine therapy, using multiple regression models. Separate models for ER+PR+ and ER-PR- cases were also run. RESULTS Patients often had T1-3N0M0, ER+PR+ cancers and received chemotherapy or endocrine therapy; only 6% were M1 and 17% ER-PR-. Diabetic patients were older and had more often high BMI (>27 kg/m(2)), ER-PR-, M1 cancers than other patients. For ER+PR+ cases, with adjustment for other variables, breast cancer mortality was higher in women with high BMI than those with BMI 23.5-27.3 kg/m(2) (hazard ratio (HR)=2.9, 95% confidence interval (CI) 1.2-6.9). Breast cancer mortality was also higher in women with high (>94 mg/dl) blood glucose compared to those with glucose 84.1-94.0mg/dl (HR=2.6, 95% CI 1.2-5.7). CONCLUSION Our results provide evidence that in ER+PR+ patients, high blood glucose and high BMI are independently associated with increased risk of breast cancer death. Detection and correction of these factors in such patients may improve prognosis.
Collapse
Affiliation(s)
- Pamela Minicozzi
- Analytical Epidemiology and Health Impact Unit, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
23
|
Amodio R, Zarcone M, Cusimano R, Campisi I, Dolcemascolo C, Traina A, Agostara B, Romano N. Target therapy in HER2-overexpressing breast cancer patients. OMICS 2011; 15:363-7. [PMID: 21568729 DOI: 10.1089/omi.2010.0125] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
The development of new therapeutic strategies, such as monoclonal antibodies directed against human epidermal growth factor receptor-2 (HER2), has offered new hopes for women with early breast cancer whose tumors overexpress HER2. We retrospectively analyzed the population-based data of Breast Cancer Registry of Palermo in 2004-2006, and selected 1401 invasive breast cancer cases, nonmetastatic at diagnosis, having HER2/neu oncogene expression determined. We have correlated this information to age, tumor stage at diagnosis (TNM), nodal involvement, and receptor status (ER and PgR). Survival analysis was conducted dividing the patients in two different groups according to date of diagnosis: one group diagnosed in 2004 and a second group in 2005-2006. In the 460 cases of 2004, nodal involvement, receptor status, age at diagnosis and TNM maintained a strong predictive value (p < 0.0001). In this group of patients, overall survival was significantly different according to the HER2 expression levels (p = 0.001). In the second group of patients (941 incident cases in 2005-2006) there was a statistically significant survival difference comparing patients with high levels of HER2 expression treated with trastuzumab versus those untreated (p = 0.006). Our data show that elevated levels of HER2 are a negative prognostic factor. In addition, patients overexpressing HER2 show a significant increase of overall survival when treated with trastuzumab.
Collapse
Affiliation(s)
- Rosalba Amodio
- Palermo Province Cancer Registry, Department of Science for the Promotion of Health G.D. Alessandro, University of Palermo, Italy.
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Miceli V, Cocciadiferro L, Fregapane M, Zarcone M, Montalto G, Polito LM, Agostara B, Granata OM, Carruba G. Expression of wild-type and variant estrogen receptor alpha in liver carcinogenesis and tumor progression. OMICS 2011; 15:313-7. [PMID: 21348637 DOI: 10.1089/omi.2010.0108] [Citation(s) in RCA: 51] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
Although estrogen receptors (ERs) are expressed in human hepatocellular carcinoma (HCC), several clinical trials have failed to demonstrate the efficacy of antiestrogen treatment in HCC patients. Recently, the identification of several ER splicing variants has enlightened the complex nature of estrogen signaling in peripheral tissues; this may help understanding estrogen role in either nontumoral or malignant nonclassical target organs, including liver. In this work we have investigated mRNA expression of wild-type and splice variants of ERα in nontumoral, cirrhotic, and malignant human liver, as well as in HCC cell lines, using an exon-specific reverse transcription polymerase chain reaction (RT-PCR). In particular, ERα66 was detected in nontumoral and, to a lesser extent, in cirrhotic liver tissues, whereas its expression decreased or became undetectable in HCC tissues and cell lines. The ERα46 splicing variant was detected ubiquitously in all samples; interestingly, however, the ERα36 variant was inversely expressed with respect to ERα66, being highest in HepG2 cells, intermediate in Huh7 cells, and lowest in HA22T cells. It is noteworthy that aromatase was correspondingly expressed with ERα36 and inversely related to ERα66. This observation suggests that a switch from ERα66 to a predominant expression of ERα36 may be associated with development and/or progression of human HCC.
Collapse
Affiliation(s)
- Vitale Miceli
- Experimental Oncology, Department of Oncology, ARNAS-Civico, Palermo, Italy
| | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Carruba G, Miceli V, Cocciadiferro L, Zarcone M, Agostara B, Montalto G, Granata OM. Estrogen signalling through amphiregulin may be implicated in human hepatocellular carcinoma. Horm Mol Biol Clin Investig 2011; 5:153-60. [PMID: 25961250 DOI: 10.1515/hmbci.2011.003] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2010] [Accepted: 01/12/2011] [Indexed: 02/07/2023]
Abstract
BACKGROUND We investigated aromatase (Aro)-driven estrogen formation in non-tumoral and malignant liver tissues and cells, also in relation to expression of the estrogen receptors α and β (ERα and ERβ) and amphiregulin (AREG), aiming to gain insights into the potential role of estrogens in human hepatocellular carcinoma (HCC). MATERIALS AND METHODS Chromatographic and reverse transcriptase polymerase chain reaction (RT-PCR) analyses were used to assess activity and expression of the Aro enzyme and AREG as well as the expression of wild-type and variant ERs, both in vivo and in vitro. RESULTS Following 24 h and 72 h incubation of liver tissues or cells with testosterone, human HCC tissues and HepG2 hepatoma cells showed elevated Aro activity (estrogen formation, respectively, of 20% and 52%-99%). By contrast, no Aro activity could be detected in non-tumoral tissues and HA22T liver cancer cells. Cirrhotic samples and Huh7 cells exhibited intermediate enzyme activity, with estrogen formation of 4% and 34%, respectively. Markedly lower or undetectable Aro mRNA levels were observed in HA22T cells and non-tumoral liver tissues compared with HepG2 cells and HCC samples. Cirrhotic specimens displayed variable transcript levels. Interestingly, no or low expression of wild-type ERα and ERβ could be observed in liver cancer cells and malignant tissues. However, ubiquitous expression of the hERα46 variant and occasional expression of the hERβ2/Cx variant were observed in cancer tissues and cells. CONCLUSIONS It is noteworthy that the pattern of wild-type ERα was inversely related to Aro, whilst AREG expression was consistently associated with that of Aro. This combined evidence suggests that locally elevated Aro activity may increase malignant cell proliferation also through AREG signalling.
Collapse
|
26
|
Amodio R, Zarcone M, Agostara B, Staiti R, Granata OM, Carruba G, Traina A. Endocrine therapy in metastatic breast cancer: data from Breast Cancer Registry of Palermo, 1999-2005 . Ann N Y Acad Sci 2009; 1155:227-31. [PMID: 19250208 DOI: 10.1111/j.1749-6632.2008.03692.x] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
This study compares the survival of breast cancer patients who are metastatic at diagnosis (DMBC) and of recurrent metastatic breast cancer (RMBC) patients. We analyzed retrospectively the population-based data of Breast Cancer Registry of Palermo and collected a total of 4459 breast cancer cases in the years 1999-2005. Survival analysis did not show statistically significant differences between DMBC and RMBC patients (P= 0.882). Endocrine manipulation is the treatment of choice in the case of hormone receptor-positive breast tumors. In 91 receptor-positive DMBC patients the endocrine treatment was associated with a prolonged overall survival (OS) (median survival 33.5 months compared to 29 months for receptor-positive patients who did not receive hormone treatment). Receptor-negative patients who underwent endocrine therapy (76% of cases) survived longer than receptor-negative patients who did not receive hormone treatment (median survival 28.5 months vs. 15 months, respectively). This evidence supports the concept that endocrine therapies impinging upon molecular targets other than hormone receptors may increase survival rates of breast cancer patients.
Collapse
Affiliation(s)
- Rosalba Amodio
- Palermo Breast Cancer Registry and Experimental Oncology Unit, Department of Oncology, ARNAS-Civico, Palermo, Italy
| | | | | | | | | | | | | |
Collapse
|
27
|
Granata OM, Traina A, Ramirez S, Campisi I, Zarcone M, Amodio R, Polito LM, Carruba G. Dietary Enterolactone Affects Androgen and Estrogen Levels in Healthy Postmenopausal Women. Ann N Y Acad Sci 2009; 1155:232-6. [DOI: 10.1111/j.1749-6632.2008.03690.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Zarcone M, Amodio R, Campisi I, Cusimano R, Dolcemascolo C, Miceli V, Traina A, Macaluso M. Application of a new classification to a breast tumor series from a population-based cancer registry: demographic, clinical, and prognostic features of incident cases, Palermo Province, 2002-2004 . Ann N Y Acad Sci 2009; 1155:222-6. [PMID: 19250207 DOI: 10.1111/j.1749-6632.2008.03693.x] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
A new classification based on gene expression profiling or immunohistochemical (IHC) characteristics may replace current histopathological classifications and predict better clinical outcomes. We used IHC markers to classify incident cases ascertained by the Palermo Breast Cancer Registry (2002-2004) into four subtypes: luminal-A (ER+ or PgR+ and HER2/neu-); luminal-B (ER+ or PgR+, HER2/neu+); basal-like (ER-, PgR-, HER2/neu-); and HER2+/ER- (HER2/neu+, ER-, PgR-). We evaluated HER2/neu, ER and PgR in 1300/1985 (65%) cases. The most common IHC-subtype was luminal-A (68%), whereas luminal-B, basal-like, and HER2+/ER- accounted for 14%, 13%, and 5%, respectively. IHC-subtypes were not associated with tumor size, geographic location within the province, or menopause, but differed by NPI (P < 0.0001), grading (P < 0.0001), lymph-node involvement (P= 0.04), metastases (P= 0.04), and TNM stage (P= 0.04). Endocrine therapy was administered to 81% of 519 postmenopausal, luminal-A, and luminal-B cases and to 32% of 114 postmenopausal, basal-like, and HER2+/ER- cases.
Collapse
Affiliation(s)
- Maurizio Zarcone
- Palermo Breast Cancer Registry and Experimental Oncology Unit, Department of Oncology, ARNAS-Civico, Palermo, Italy
| | | | | | | | | | | | | | | |
Collapse
|
29
|
Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, Finarelli AC, Foca F, Mangone L, Naldoni C, Petrella M, Ponti A, Segnan N, Sigona A, Zarcone M, Zorzi M, Zappa M, Paci E. Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 2008; 99:423-7. [PMID: 18665188 PMCID: PMC2527797 DOI: 10.1038/sj.bjc.6604532] [Citation(s) in RCA: 62] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2008] [Revised: 06/20/2008] [Accepted: 06/30/2008] [Indexed: 11/09/2022] Open
Abstract
The aim of this study was the evaluation of the impact of service screening programmes on breast cancer mortality in five regions of Italy. We conducted a matched case-control study with four controls for each case. Cases were defined as breast cancer deaths occurred not later than 31 December 2002. Controls were sampled from the local municipality list and matched by date of birth. Screening histories were assessed by the local, computerised, screening database and subjects were classified as either invited or not-yet-invited and as either screened or unscreened. There were a total of 1750 breast cancer deaths within the 50 to 74-year-old breast cancer cases and a total of 7000 controls. The logistic conditional estimate of the cumulative odds ratios comparing invited with not-yet-invited women was 0.75 (95% CI: 0.62-0.92). Restricting the analyses to invited women, the odds ratio of screened to never-respondent women corrected for self-selection bias was 0.55 (95% CI: 0.36-0.85). The introduction of breast cancer screening programmes in Italy is associated with a reduction in breast cancer mortality attributable to the additional impact of service screening over and above the background access to mammography.
Collapse
Affiliation(s)
- D Puliti
- Clinical and Descriptive Epidemiology Unit, CSPO, Research Institute of the Tuscany Region, via San Salvi 12, Florence 50135, Italy
| | - G Miccinesi
- Clinical and Descriptive Epidemiology Unit, CSPO, Research Institute of the Tuscany Region, via San Salvi 12, Florence 50135, Italy
| | - N Collina
- AUSL Bologna, Via del Seminario 1, S.Lazzaro di Savena, Bologna 40068, Italy
| | - V De Lisi
- Parma Cancer Registry, via Abbeveratoia 4, Parma 43100, Italy
| | - M Federico
- Modena Cancer Registry, via del Pozzo 71, Modena 41100, Italy
| | - S Ferretti
- Ferrara Cancer Registry, via Fossato di Mortara 64b, Ferrara 44100, Italy
| | - A C Finarelli
- Emilia-Romagna Region Health Department, viale Aldo Moro 21, Bologna 40127, Italy
| | - F Foca
- Romagna Cancer Registry, via Carlo Forlanini 34, Forlì 47100, Italy
| | - L Mangone
- Reggio Emilia Cancer Registry, via Amendola 2, Reggio Emilia 42100, Italy
| | - C Naldoni
- Emilia-Romagna Region Health Department, viale Aldo Moro 21, Bologna 40127, Italy
| | - M Petrella
- Epidemiology Unit ASL2, via XIV Settembre 79, Perugia 06100, Italy
| | - A Ponti
- Epidemiology Unit, CPO Piemonte, via S. Francesco da Paola 31, Torino 10123, Italy
| | - N Segnan
- Epidemiology Unit, CPO Piemonte, via S. Francesco da Paola 31, Torino 10123, Italy
| | - A Sigona
- Cancer Registry, A.O. ‘Civile M.P. Arezzo’, via Dante 109, Ragusa 97100, Italy
| | - M Zarcone
- Palermo Breast Cancer Registry, Piazzale N. Leotta 2, Palermo 90127, Italy
| | - M Zorzi
- Venetian Tumour Registry, Istituto Oncologico Veneto, via Gattamelata 64, Padua 35128, Italy
| | - M Zappa
- Clinical and Descriptive Epidemiology Unit, CSPO, Research Institute of the Tuscany Region, via San Salvi 12, Florence 50135, Italy
| | - E Paci
- Clinical and Descriptive Epidemiology Unit, CSPO, Research Institute of the Tuscany Region, via San Salvi 12, Florence 50135, Italy
| | - the IMPACT Working Group
- Clinical and Descriptive Epidemiology Unit, CSPO, Research Institute of the Tuscany Region, via San Salvi 12, Florence 50135, Italy
- AUSL Bologna, Via del Seminario 1, S.Lazzaro di Savena, Bologna 40068, Italy
- Parma Cancer Registry, via Abbeveratoia 4, Parma 43100, Italy
- Modena Cancer Registry, via del Pozzo 71, Modena 41100, Italy
- Ferrara Cancer Registry, via Fossato di Mortara 64b, Ferrara 44100, Italy
- Emilia-Romagna Region Health Department, viale Aldo Moro 21, Bologna 40127, Italy
- Romagna Cancer Registry, via Carlo Forlanini 34, Forlì 47100, Italy
- Reggio Emilia Cancer Registry, via Amendola 2, Reggio Emilia 42100, Italy
- Epidemiology Unit ASL2, via XIV Settembre 79, Perugia 06100, Italy
- Epidemiology Unit, CPO Piemonte, via S. Francesco da Paola 31, Torino 10123, Italy
- Cancer Registry, A.O. ‘Civile M.P. Arezzo’, via Dante 109, Ragusa 97100, Italy
- Palermo Breast Cancer Registry, Piazzale N. Leotta 2, Palermo 90127, Italy
- Venetian Tumour Registry, Istituto Oncologico Veneto, via Gattamelata 64, Padua 35128, Italy
| |
Collapse
|
30
|
Traina A, Agostara B, Marasà L, Calabrò M, Zarcone M, Carruba G. HER2/neu expression in relation to clinicopathologic features of breast cancer patients. Ann N Y Acad Sci 2007; 1089:159-67. [PMID: 17261764 DOI: 10.1196/annals.1386.029] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We have evaluated HER2/neu expression in 1,355 breast cancer patients recruited at the Breast Cancer Registry in Palermo between January 1999 and December 2004. In this retrospective study, HER2/neu expression was related to clinicopathologic features of the disease, including tumor size, nodal and menopausal status, estrogen and progesterone receptors. Statistical analysis on all 1,355 patients showed a significant correlation between HER2/neu and nodal status (P < 0.001), and a significant association between HER2/neu overexpression and estrogen and progesterone receptors status (P < 0.001). In 194 patients without metastasis, with an average follow-up > or =5 years, only HER2/neu 3+ and histopathologic grading G3 were significantly associated with overall survival.
Collapse
Affiliation(s)
- Adele Traina
- Experimental Oncology, Department of Oncology, P.O. M. Ascoli, via Parlavecchio n. 139, 90127 Palermo, Italy.
| | | | | | | | | | | |
Collapse
|
31
|
Traina A, Cusimano R, Ravazzolo B, Amodio R, Zarcone M, Dolcemascolo C, Polito L, Carruba G. Comparison of Female Breast Cancer Registration in the City and Province of Palermo With Other Italian Cancer Registries. Nutr Cancer 2006; 56:241-6. [PMID: 17474871 DOI: 10.1207/s15327914nc5602_16] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
The aim of this study was to assess the incidence of breast cancer in women from the city and province of Palermo (Sicily) in 5 yr, 1999-2003, using a population based cancer registry approach. In the last years, a sharp increase of breast cancer incidence has been observed worldwide. Overall, direct age-standardized incidence rates were 89.3 per 100,000 person-yr, being markedly higher in Palermo City (101.0) than in Palermo Province (75.0). Results show a highly significant difference in breast cancer incidence in different areas of Sicily, particularly in the older (>50 yr) age groups and a profound difference between the metropolitan area of Palermo and the surrounding areas. The evidence of the different rates of breast cancer incidence in Palermo City and in the other small municipalities of the Palermo Province suggests a different pattern of breast cancer risk as a consequence of different lifestyle and diet modifications in the urban population of Palermo City.
Collapse
Affiliation(s)
- Adele Traina
- Breast Cancer Registry and Experimental Oncology, Department of Oncology, ARNAS-Civico, Palermo, Italy
| | | | | | | | | | | | | | | |
Collapse
|
32
|
Ferrante G, Zarcone M, Uryupin SA. Third-harmonic generation in the skin layer of a hot dense plasma. Phys Rev E Stat Nonlin Soft Matter Phys 2004; 70:016403. [PMID: 15324174 DOI: 10.1103/physreve.70.016403] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/11/2003] [Indexed: 05/24/2023]
Abstract
The third-harmonic generation of a pump wave, resulting from the electron-ion collision frequency dependence on the electric field in the skin layer of a hot dense plasma is investigated. The relation of the current third harmonic with the high-frequency field in the skin layer is established for arbitrary ratios of the electron-ion collision frequency to the field frequency. For arbitrary ratios of these two frequencies, the field structure inside the skin layer is determined, and the field of the wave irradiated by the plasma at tripled frequency, too, is calculated. It has permitted us to find the explicit dependencies of the third-harmonic generation efficiency on the plasma and pump field parameters.
Collapse
Affiliation(s)
- G Ferrante
- Istituto Nazionale per la Fisica della Materia and Dipartimento di Fisica e Tecnologie Relative, Viale delle Scienze, edificio 18, 90128 Palermo, Italy
| | | | | |
Collapse
|
33
|
Ferrante G, Zarcone M, Uryupin SA. Anomalous transmission of an ultrashort ionizing laser pulse through a thin foil. Phys Rev Lett 2003; 91:085005. [PMID: 14525249 DOI: 10.1103/physrevlett.91.085005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/26/2002] [Indexed: 05/24/2023]
Abstract
The formation of a highly anisotropic photoelectron velocity distribution as a result of the interaction of a powerful ultrashort laser pulse with a thin foil is found to yield a large skin-layer depth and an anomalous increase of the transmission coefficient. The physical reason for the effect is the influence of the incident wave magnetic field, through the Lorenz force, on the electron kinetics in the skin layer.
Collapse
Affiliation(s)
- G Ferrante
- Istituto Nazionale per la Fisica della Materia and Dipartimento di Fisica e Tecnologie Relative, Viale delle Scienze, 90128 Palermo, Italy
| | | | | |
Collapse
|
34
|
Shiktorov P, Starikov E, Gru?inskis V, Zarcone M, Persano Adorno D, Ferrante G, Reggiani L, Varani L, Vaissi�re J. Monte Carlo Analysis of the Efficiency of Tera-Hertz Harmonic Generation in Semiconductor Nitrides. ACTA ACUST UNITED AC 2002. [DOI: 10.1002/1521-396x(200203)190:1<271::aid-pssa271>3.0.co;2-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
|
35
|
Ferrante G, Zarcone M, Uryupin SA. Plasma electron kinetics in a weak high-frequency field and magnetic field amplification. Phys Rev E Stat Nonlin Soft Matter Phys 2001; 64:046408. [PMID: 11690157 DOI: 10.1103/physreve.64.046408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2000] [Revised: 02/26/2001] [Indexed: 05/23/2023]
Abstract
We describe the linear stage of Weibel instability in a plasma heated via inverse bremsstrahlung absorption of a high-frequency, moderate intensity radiation field under conditions in which the plasma electron velocity distribution function is weakly anisotropic. We report on the possibility of a significant amplification of spontaneous magnetic fields both in the case of an electron distribution function slightly departing from a Maxwellian in the region of subthermal velocities, and in the case where the Langdon nonequilibrium distribution is formed. We show that the direct influence of collisions on the Weibel instability growth rate may be traced back to subthermal electrons, for which the effective collision frequency is large.
Collapse
Affiliation(s)
- G Ferrante
- Istituto Nazionale per la Fisica della Materia and Dipartimento di Fisica e Tecnologie Relative, Viale delle Scienze, 90128 Palermo, Italy
| | | | | |
Collapse
|
36
|
Zarcone M, Nuzzo S. Potential scattering T matrix in a strong static magnetic field and a collinear low-frequency radiation field. Phys Rev A 1995; 52:2185-2194. [PMID: 9912479 DOI: 10.1103/physreva.52.2185] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/11/2023]
|
37
|
Pieruccini M, Ferrante G, Nuzzo S, Zarcone M. Langevin approach to collisional bremsstrahlung in a magnetic field. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1994; 49:678-686. [PMID: 9961262 DOI: 10.1103/physreve.49.678] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
|
38
|
Porshnev P, Ferrante G, Zarcone M. Electron distribution functions in laser-embedded plasmas. Phys Rev E Stat Phys Plasmas Fluids Relat Interdiscip Topics 1993; 48:2081-2086. [PMID: 9960822 DOI: 10.1103/physreve.48.2081] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 04/12/2023]
|
39
|
|